首页 > 最新文献

HSOA journal of stem cells research, development & therapy最新文献

英文 中文
Bone Marrow Aspirate for Delayed Union due to Severe Thoracic Rib Trauma 骨髓抽吸术治疗严重胸肋创伤延迟愈合
Pub Date : 2021-09-03 DOI: 10.24966/srdt-2060/100077
Marcelo Braga
In this peculiar setting, the infiltrations with BMA proved to be an efficient alternative tool for the treatment of severe thoracic rib trauma and delayed union. The patient returned with no complaints and CT evidence indicated that all of the fractured ribs had complete consolidation. Pain and functional outcome of the chest wall in terms of stability improved with the help of this orthobiologic alternative.
在这种特殊的情况下,BMA浸润被证明是治疗严重胸椎创伤和延迟愈合的有效替代工具。患者无任何症状返回,CT显示所有骨折的肋骨已完全巩固。胸壁的疼痛和功能在稳定性方面得到了改善。
{"title":"Bone Marrow Aspirate for Delayed Union due to Severe Thoracic Rib Trauma","authors":"Marcelo Braga","doi":"10.24966/srdt-2060/100077","DOIUrl":"https://doi.org/10.24966/srdt-2060/100077","url":null,"abstract":"In this peculiar setting, the infiltrations with BMA proved to be an efficient alternative tool for the treatment of severe thoracic rib trauma and delayed union. The patient returned with no complaints and CT evidence indicated that all of the fractured ribs had complete consolidation. Pain and functional outcome of the chest wall in terms of stability improved with the help of this orthobiologic alternative.","PeriodicalId":93004,"journal":{"name":"HSOA journal of stem cells research, development & therapy","volume":"77 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78754927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cell Therapy Moving in the Right Direction 细胞疗法正朝着正确的方向发展
Pub Date : 2021-06-21 DOI: 10.24966/srdt-2060/100074
M. Valadares, São Paulo Brazil Pluricell Biotech
Recently, Biagi et al., 2021 published results of yet another successful demonstration of how hiPSC-derived cardiomyocytes can engraft in rats' hearts and improve their cardiac function [1]. According to the work, these results are probably due to the segmental improvement in areas where the grafts were found
最近,Biagi等人于2021年发表了另一项成功的实验结果,证明hipsc来源的心肌细胞可以植入大鼠心脏并改善其心功能[1]。根据这项工作,这些结果可能是由于发现移植物的区域的节段改善
{"title":"Cell Therapy Moving in the Right Direction","authors":"M. Valadares, São Paulo Brazil Pluricell Biotech","doi":"10.24966/srdt-2060/100074","DOIUrl":"https://doi.org/10.24966/srdt-2060/100074","url":null,"abstract":"Recently, Biagi et al., 2021 published results of yet another successful demonstration of how hiPSC-derived cardiomyocytes can engraft in rats' hearts and improve their cardiac function [1]. According to the work, these results are probably due to the segmental improvement in areas where the grafts were found","PeriodicalId":93004,"journal":{"name":"HSOA journal of stem cells research, development & therapy","volume":"31 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74951200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cancer Stem Cell Assay for the Treatment of Platinum-Resistant Recurrent Ovarian Cancer. 肿瘤干细胞试验治疗铂耐药复发性卵巢癌。
Pub Date : 2021-01-01 Epub Date: 2021-09-09 DOI: 10.24966/srdt-2060/100076
Candace M Howard, Stephen Bush, Nadim Bou Zgheib, Seth T Lirette, Antonio Cortese, Antonio Mollo, Jagan Valluri, Pier Paolo Claudio

Background: Disease recurrence and progression of ovarian cancer is a common event, which is accompanied by the development of platinum-resistant or refractory disease. The presence of chemo-resistant Cancer Stem Cells (CSCs) contribute to tumor propagation, maintenance, and treatment resistance of this difficult to treat disease. We have developed ChemoID, a cytotoxic synergy assay against CSCs that identifies the most effective chemotherapy treatment from a panel of FDA-approved chemotherapies using fresh cancer biopsies.

Patients and methods: Ascites or interventional radiology biopsies were collected under physician order from 78 consecutive patients affected by 3rd relapsed ovarian cancer. Test results from the assay were used when possible to treat patients with the highest cell kill drugs, taking into consideration their health status and using dose reductions, if needed. A chart analysis and review of CT and PET scans were performed to determine patients' outcomes for tumor response, Progression-Free Survival (PFS), and Overall Survival (OS).

Results: We observed that recurrent ovarian cancer patients treated with high-cell kill chemotherapy agents guided by the CSCs drug response assay had an improvement in their median PFS and OS when compared to historical median PFS and OS and/or when compared to patients who could not receive high cell kill chemotherapies (PFS low cell kill 3.5 months vs. high cell kill 12.0 months; OS low cell kill 6.0 months vs. high cell kill 15.0 months).

Conclusion: This data indicates that the drug cytotoxicity assay aimed at targeting CSCs may be a useful tool for optimizing treatment selection when first-line therapy fails, and when there are multiple clinically-acceptable and -equivalent treatments available.

背景:癌症的疾病复发和进展是一种常见的事件,伴随着铂耐药性或难治性疾病的发展。耐药癌症干细胞(CSCs)的存在有助于这种难以治疗的疾病的肿瘤传播、维持和治疗耐药性。我们开发了ChemoID,这是一种针对CSC的细胞毒性协同试验,通过使用新鲜癌症活组织检查,从一组FDA批准的化疗中确定最有效的化疗治疗。患者和方法:根据医师指示,从连续78例癌症3期复发患者中收集腹水或介入放射学活组织检查。在可能的情况下,使用该测定的测试结果来治疗使用最高细胞杀伤药物的患者,考虑到他们的健康状况,并在需要时减少剂量。对CT和PET扫描进行图表分析和回顾以确定患者的肿瘤反应、无进展生存期(PFS)和无进展生存率(PFS)的结果,结果:我们观察到,与历史中位PFS和OS相比,和/或与不能接受高细胞杀伤化疗的患者相比,接受CSCs药物反应分析指导的高级细胞杀伤化疗剂治疗的复发性卵巢癌症患者的中位PFS或OS有所改善(PFS低细胞杀伤3.5个月对高细胞杀伤12.0个月;OS低细胞杀伤6.0个月对高细胞杀伤15.0个月)。结论:该数据表明,当一线治疗失败时,以及当有多种临床可接受和等效的治疗可用时,针对CSCs的药物细胞毒性测定可能是优化治疗选择的有用工具。
{"title":"Cancer Stem Cell Assay for the Treatment of Platinum-Resistant Recurrent Ovarian Cancer.","authors":"Candace M Howard,&nbsp;Stephen Bush,&nbsp;Nadim Bou Zgheib,&nbsp;Seth T Lirette,&nbsp;Antonio Cortese,&nbsp;Antonio Mollo,&nbsp;Jagan Valluri,&nbsp;Pier Paolo Claudio","doi":"10.24966/srdt-2060/100076","DOIUrl":"10.24966/srdt-2060/100076","url":null,"abstract":"<p><strong>Background: </strong>Disease recurrence and progression of ovarian cancer is a common event, which is accompanied by the development of platinum-resistant or refractory disease. The presence of chemo-resistant Cancer Stem Cells (CSCs) contribute to tumor propagation, maintenance, and treatment resistance of this difficult to treat disease. We have developed ChemoID, a cytotoxic synergy assay against CSCs that identifies the most effective chemotherapy treatment from a panel of FDA-approved chemotherapies using fresh cancer biopsies.</p><p><strong>Patients and methods: </strong>Ascites or interventional radiology biopsies were collected under physician order from 78 consecutive patients affected by 3<sup>rd</sup> relapsed ovarian cancer. Test results from the assay were used when possible to treat patients with the highest cell kill drugs, taking into consideration their health status and using dose reductions, if needed. A chart analysis and review of CT and PET scans were performed to determine patients' outcomes for tumor response, Progression-Free Survival (PFS), and Overall Survival (OS).</p><p><strong>Results: </strong>We observed that recurrent ovarian cancer patients treated with high-cell kill chemotherapy agents guided by the CSCs drug response assay had an improvement in their median PFS and OS when compared to historical median PFS and OS and/or when compared to patients who could not receive high cell kill chemotherapies (PFS low cell kill 3.5 months vs. high cell kill 12.0 months; OS low cell kill 6.0 months vs. high cell kill 15.0 months).</p><p><strong>Conclusion: </strong>This data indicates that the drug cytotoxicity assay aimed at targeting CSCs may be a useful tool for optimizing treatment selection when first-line therapy fails, and when there are multiple clinically-acceptable and -equivalent treatments available.</p>","PeriodicalId":93004,"journal":{"name":"HSOA journal of stem cells research, development & therapy","volume":"7 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597976/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39637808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Development Of A Human Pluripotency Sensor For Real-Time Cell Imaging And Biomedical Applications 用于实时细胞成像和生物医学应用的人体多能传感器的研制
Pub Date : 2020-12-23 DOI: 10.24966/srdt-2060/100055
Jeong Beom Kim
uman Pluripotent Stem Cells (hPSCs) are an essential cell source for regenerative medicine. With the increasing importance of hPSCs for cell-based therapy, the need for hPSCs in basic and clinical research is to develop live-cell imaging systems that monitor hPSCs during reprogramming or differentiation processes
人多能干细胞(hPSCs)是再生医学的重要细胞来源。随着人乳头状细胞干细胞在细胞治疗中的重要性日益增加,在基础和临床研究中对人乳头状细胞干细胞的需求是开发活细胞成像系统,在重编程或分化过程中监测人乳头状细胞干细胞
{"title":"Development Of A Human Pluripotency Sensor For Real-Time Cell Imaging And Biomedical Applications","authors":"Jeong Beom Kim","doi":"10.24966/srdt-2060/100055","DOIUrl":"https://doi.org/10.24966/srdt-2060/100055","url":null,"abstract":"uman Pluripotent Stem Cells (hPSCs) are an essential cell source for regenerative medicine. With the increasing importance of hPSCs for cell-based therapy, the need for hPSCs in basic and clinical research is to develop live-cell imaging systems that monitor hPSCs during reprogramming or differentiation processes","PeriodicalId":93004,"journal":{"name":"HSOA journal of stem cells research, development & therapy","volume":"70 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79725214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regenerative Medicine In An Elite Football Athlete: A Case Report 再生医学在一个优秀的足球运动员:一个案例报告
Pub Date : 2020-12-23 DOI: 10.24966/srdt-2060/100059
M. F. Viña, Argentina Clínica San Nicolás S.A
Osteoarthritis (OA) is a degenerative disorder resulting from loss of joint cartilage and underlying bone. Sports injuries are considered disorders of the musculoskeletal system or concussions that are generally caused during sportive activities such as football
骨关节炎(OA)是一种退行性疾病,由关节软骨和底层骨的丧失引起。运动损伤被认为是肌肉骨骼系统的紊乱或脑震荡,通常是在足球等体育活动中引起的
{"title":"Regenerative Medicine In An Elite Football Athlete: A Case Report","authors":"M. F. Viña, Argentina Clínica San Nicolás S.A","doi":"10.24966/srdt-2060/100059","DOIUrl":"https://doi.org/10.24966/srdt-2060/100059","url":null,"abstract":"Osteoarthritis (OA) is a degenerative disorder resulting from loss of joint cartilage and underlying bone. Sports injuries are considered disorders of the musculoskeletal system or concussions that are generally caused during sportive activities such as football","PeriodicalId":93004,"journal":{"name":"HSOA journal of stem cells research, development & therapy","volume":"50 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75823872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhanced Bone Regeneration With Umbilical Cord Stem Cells: A Case Report And Histomorphometric Analysis 脐带干细胞增强骨再生:一例报告和组织形态学分析
Pub Date : 2020-12-23 DOI: 10.24966/srdt-2060/100054
D. Smiler
Combining bone-marrow aspirate with xenograft and allograft particulate material has been demonstrated to produce a significant quantity of new bone growth. However, securing 1 to 4 ccs of adult autogenous stem cells by means of bone-marrow aspiration is invasive, and the aspirated stem cells are typically senescent, as the procedure most often is used in aging patients
将骨髓抽吸液与异种移植物和同种异体移植物颗粒材料相结合已被证明可以产生大量的新骨生长。然而,通过骨髓抽吸获得1 - 4cc的成体自体干细胞是侵入性的,而且抽吸的干细胞通常是衰老的,因为这种方法最常用于老年患者
{"title":"Enhanced Bone Regeneration With Umbilical Cord Stem Cells: A Case Report And Histomorphometric Analysis","authors":"D. Smiler","doi":"10.24966/srdt-2060/100054","DOIUrl":"https://doi.org/10.24966/srdt-2060/100054","url":null,"abstract":"Combining bone-marrow aspirate with xenograft and allograft particulate material has been demonstrated to produce a significant quantity of new bone growth. However, securing 1 to 4 ccs of adult autogenous stem cells by means of bone-marrow aspiration is invasive, and the aspirated stem cells are typically senescent, as the procedure most often is used in aging patients","PeriodicalId":93004,"journal":{"name":"HSOA journal of stem cells research, development & therapy","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78234748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Would The End Of COVID-19 Infection As A Chronic Disease? COVID-19感染的终结会成为一种慢性病吗?
Pub Date : 2020-12-23 DOI: 10.24966/srdt-2060/100057
Khoa Nguyen
Although highly transmissible due to its highly infectious nature, since a large proportion of cases are asymptomatic or mild, self-awareness which promotes the spread of the disease worldwide. The public health manages against Corona virus should reduce the numbers of people infected with influenza virus to avoid the two viruses infections will be interacted
虽然由于其高度传染性而具有高度传染性,但由于很大一部分病例是无症状或轻微的,因此自我意识促进了该疾病在世界范围内的传播。针对冠状病毒的公共卫生管理应减少流感病毒感染人数,避免两种病毒感染相互作用
{"title":"Would The End Of COVID-19 Infection As A Chronic Disease?","authors":"Khoa Nguyen","doi":"10.24966/srdt-2060/100057","DOIUrl":"https://doi.org/10.24966/srdt-2060/100057","url":null,"abstract":"Although highly transmissible due to its highly infectious nature, since a large proportion of cases are asymptomatic or mild, self-awareness which promotes the spread of the disease worldwide. The public health manages against Corona virus should reduce the numbers of people infected with influenza virus to avoid the two viruses infections will be interacted","PeriodicalId":93004,"journal":{"name":"HSOA journal of stem cells research, development & therapy","volume":"50 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82645870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Maxillary Split Crest And Sinus Augmentation With Piezosurgery And Growth Factors 利用压电外科和生长因子增强上颌裂冠和窦
Pub Date : 2020-12-23 DOI: 10.24966/srdt-2060/100058
M. Serafini
One of the most common anatomic limitation which prevents a correct implant placement, is horizontal and vertical bone deficiency. Modern surgical techniques allow predictable rehabilitation of these severe defects, using on one side the great regenerative potential of autologous growth factors, on the other side instruments that allow more bone preservation and less trauma on hard and soft tissues, crucial criteria for successful surgeries
最常见的解剖学限制之一是水平和垂直骨缺乏,这阻碍了正确的种植体放置。现代外科技术允许对这些严重的缺陷进行可预测的康复,一方面利用自体生长因子的巨大再生潜力,另一方面利用工具可以保留更多的骨骼,减少对硬组织和软组织的创伤,这是手术成功的关键标准
{"title":"Maxillary Split Crest And Sinus Augmentation With Piezosurgery And Growth Factors","authors":"M. Serafini","doi":"10.24966/srdt-2060/100058","DOIUrl":"https://doi.org/10.24966/srdt-2060/100058","url":null,"abstract":"One of the most common anatomic limitation which prevents a correct implant placement, is horizontal and vertical bone deficiency. Modern surgical techniques allow predictable rehabilitation of these severe defects, using on one side the great regenerative potential of autologous growth factors, on the other side instruments that allow more bone preservation and less trauma on hard and soft tissues, crucial criteria for successful surgeries","PeriodicalId":93004,"journal":{"name":"HSOA journal of stem cells research, development & therapy","volume":"20 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86033756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring Stem Cell Differentiation From A Mechanobiological Perspective: Insights From Neural Precursor Cells And Beyond 从机械生物学角度探索干细胞分化:来自神经前体细胞及其他方面的见解
Pub Date : 2020-11-13 DOI: 10.24966/srdt-2060/100053
B. Pontes
The surface of mammalian cells consists of the plasma membrane lined by an underneath cortical actomyosin cytoskeleton. This pair of structures forms the Membrane-Cytoskeleton Complex (MCC), a known regulator of cellular processes, ranging from shape control and cell migration to molecule presentation and signaling [1-3].
哺乳动物细胞的表面由质膜组成,质膜下面衬有皮层下的肌动球蛋白细胞骨架。这对结构形成了膜-细胞骨架复合物(MCC),是一种已知的细胞过程调节剂,从形状控制和细胞迁移到分子呈现和信号传导[1-3]。
{"title":"Exploring Stem Cell Differentiation From A Mechanobiological Perspective: Insights From Neural Precursor Cells And Beyond","authors":"B. Pontes","doi":"10.24966/srdt-2060/100053","DOIUrl":"https://doi.org/10.24966/srdt-2060/100053","url":null,"abstract":"The surface of mammalian cells consists of the plasma membrane lined by an underneath cortical actomyosin cytoskeleton. This pair of structures forms the Membrane-Cytoskeleton Complex (MCC), a known regulator of cellular processes, ranging from shape control and cell migration to molecule presentation and signaling [1-3].","PeriodicalId":93004,"journal":{"name":"HSOA journal of stem cells research, development & therapy","volume":"153 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73153881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review: Extracellular Vesicles From Human Liver Stem Cells As An Alternative Therapeutic Approach For The Treatment Of Urea Cycle Diseases 综述:来自人肝干细胞的细胞外囊泡作为治疗尿素循环疾病的替代治疗方法
Pub Date : 2020-06-23 DOI: 10.24966/srdt-2060/100039
Maria Beatriz Herrera Sanchez
{"title":"Review: Extracellular Vesicles From Human Liver Stem Cells As An Alternative Therapeutic Approach For The Treatment Of Urea Cycle Diseases","authors":"Maria Beatriz Herrera Sanchez","doi":"10.24966/srdt-2060/100039","DOIUrl":"https://doi.org/10.24966/srdt-2060/100039","url":null,"abstract":"","PeriodicalId":93004,"journal":{"name":"HSOA journal of stem cells research, development & therapy","volume":"106 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78777682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
HSOA journal of stem cells research, development & therapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1